Company: SNWV
Filing Date: 2025-07-31
Form Type: 8-K
Source: 0001628280-25-037048
Chunk: 0

Company: SANUWAVE Health, Inc.
Filing Date: 2025-07-31
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously disclosed, on May 30, 2025, Nanci Gilmore, the former Chief Commercial Officer of Sanuwave Health, Inc. (the “ Company”), was terminated without cause, effective as of the same date. On July 28, 2025, Ms. Gilmore and the Company entered into a Separation and Release Agreement (the “ Separation Agreement”), pursuant to which Ms. Gilmore will receive a lump sum cash payment of (i) five months’ annual base salary in the amount of $97,916.70 and (ii) a pro-rated bonus in the amount of $14,790.81, in each case, less applicable federal and state taxes. In addition, the Separation Agreement provides that Ms. Gilmore’s employee stock options will continue to vest throughJanuary 31,2026 and shall remain outstanding and exercisable until their respective expiration dates. The Severance Agreement also includes a release of claims in favor of the Company and customary confidentiality and non-disparagement provisions.

The foregoing description of the Separation Agreement does not purport to be complete and is qualified by reference to the full text of the Separation Agreement, which is filed hereto as Exhibit 10.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.